Some of the most valuable things a business owns cannot be touched: a patent, a brand it bought, the know-how from a development project. Accounting has to decide which of these to record as assets, how to spread their cost, and when to write them down. A write-down is also needed for physical assets when they are no longer worth their carrying amount.
This topic covers intangible assets and the treatment of research and development, amortisation, and the test for impairment of any asset, including how to measure the recoverable amount.
These are new items in the syllabus. In the 20 diets reviewed only a 2-mark definition and a few Section A items touch them, so expect direct questions in the new papers, usually a classification of spending as research or development, an amortisation calculation, or an impairment loss. Read the topic on depreciation first, because amortisation works the same way. The next topic covers inventory.
In 30 seconds
An Intangible asset is an identifiable non-monetary asset without physical substance, such as a patent, copyright or trademark. Research spending is always an expense. Development spending is capitalised only if all six criteria are met. A finite-life intangible is Amortised (straight-line if the pattern is unknown). An indefinite-life one is not amortised but is tested for impairment each year.
An asset is Impaired when its carrying amount exceeds its Recoverable amount, which is the higher of Fair value less costs to sell and Value in use. The loss goes to profit or loss, and is written down to the recoverable amount. A reversal can never lift the carrying amount above what it would have been with no impairment.
Intangible assets
Intangible assets are identifiable non-monetary assets without physical substance (IAS 38, paragraph 8). Patents, copyrights, trademarks and goodwill are common examples. They have these characteristics:
- No physical substance. They cannot be seen or touched: trademarks, patents, copyrights, goodwill, software, brand names.
- Identifiability. The asset is separately acquired or can be separated and sold, transferred, licensed or exchanged, or it arises from contractual or legal rights.
- Non-monetary. There is no right to receive a fixed or determinable amount of money.
- Control. The entity can restrict others from the economic benefits.
- Expected future economic benefits, such as more revenue, savings or efficiency.
- Measurable cost or value.
- Finite or indefinite useful life. A finite life is amortised. An indefinite life is not amortised but is tested annually for impairment.
| Point | Tangible assets | Intangible assets |
|---|---|---|
| Form | Physical: land, buildings, equipment | None |
| Valuation | Easier, by cost or market value | More subjective and needs expert judgement |
| How obtained | Purchased or constructed | Purchased, or developed internally through research and innovation |
| Capitalising the cost | As IAS 16 allows | Only if criteria are met. Internally developed ones need the IAS 38 conditions |
| Useful life | Usually finite, so depreciated | Finite (amortised) or indefinite (not amortised, tested annually) |
There are four types: Patents (exclusive rights for inventions for a period), Copyrights (rights over original creative works), Trademarks (identifiers of a brand or product) and Goodwill (the excess of the purchase consideration over the fair value of the identifiable net assets in a business combination).
Background: IAS 38 does not allow internally generated goodwill, brands, mastheads, publishing titles or customer lists to be recognised, because their cost cannot be separated from the cost of developing the business as a whole (paragraph 63). Only purchased ones are recognised.
Research and development
R&D expenditure is the cost of developing new or improved products, processes or services. Research aims to gain new knowledge. Development applies research findings to create or improve products or processes. All research costs must be Expensed as incurred (IAS 38, paragraph 54). Development costs are capitalised only if All of these are met (paragraph 57).
- Technical feasibility of completing the asset for use or sale.
- Intention to complete and use or sell it.
- Ability to use or sell it.
- Reliable measurement of the expenditure attributable to it.
- Future economic benefits that are probable.
- Adequate resources, technical, financial and other, to complete and use or sell it.
Internally generated intangibles may be recognised only from the development phase, and research costs are always expensed. The cost of an intangible includes direct development costs, such as labour, materials and overheads, or the purchase price for an acquired one. Examples. Testing a production prototype is development and is capitalised if the criteria are met, otherwise expensed. A search for alternative production processes is research and is expensed.
A substantial cost of building a prototype of a new heat-resistant suit is development. Testing whether a newly found substance is waterproof is research and is expensed. An advertising campaign is an expense. It is not an intangible asset under IAS 38.
Amortisation and carrying amount
Amortisation allocates the cost of an intangible asset over its useful life, as depreciation does for tangible assets. If the pattern of benefits cannot be reliably determined, use the straight-line method. Indefinite-life assets, such as brand names and trademarks with no limit on the period of cash flows and no legal or contractual limit, are Not amortised but are tested at least annually for impairment (IAS 36, paragraph 10). The carrying amount is:
Carrying amount = cost − accumulated amortisation − accumulated impairment losses
For example, a patent bought for ₦1,800,000 on 1 January with a six-year life is amortised at ₦300,000 a year (Dr Amortisation expense, Cr Accumulated amortisation), and the carrying amount after two years is ₦1,200,000. Development costs of ₦900,000 capitalised with a five-year life, with benefits starting on 1 July, are amortised at 900,000 ÷ 5 × 6/12 = ₦90,000 in the first year.
The cost of intangible assets is disclosed by class, with the amortisation method and rate, any impairment losses, and a reconciliation of the opening and closing carrying amounts showing additions, disposals, amortisation and impairment.
Impairment of assets
An asset is impaired when its carrying amount exceeds its Recoverable amount (IAS 36, paragraph 6). The principle is that an asset must not be carried at more than the highest amount recoverable through use or sale, which applies the prudence concept. An entity assesses at the end of each reporting period whether there is any indication of impairment (IAS 36, paragraph 9).
Some assets must be tested every year even without an indication (paragraph 10):
- intangible assets with an indefinite useful life;
- intangible assets not yet available for use; and
- acquired goodwill.
Indicators include a significant fall in market value, adverse changes in the technological, market, legal or economic environment, physical damage or obsolescence, and plans to dispose of or restructure the asset (paragraph 12).
Recoverable amount
Recoverable amount = the higher of fair value less costs to sell (FVLCTS) and value in use (VIU)
- FVLCTS is what the asset would fetch in an arm’s-length sale less the costs of disposal, such as legal fees, removal costs and commissions. A property that can be sold for ₦6,400,000 with ₦240,000 of selling costs has an FVLCTS of ₦6,160,000.
- VIU is the present value of the future cash flows expected from continued use. Estimate the cash flows, choose a discount rate and compute the present value of each year’s flow.
Recognising and reversing the loss
An impairment loss is recognised when the carrying amount exceeds the recoverable amount. It is recognised in Profit or loss (IAS 36, paragraph 60). If the asset has been revalued, the loss is first treated as a revaluation decrease, in other comprehensive income, to the extent of the existing revaluation surplus on that asset. After the loss, the carrying amount equals the recoverable amount.
A loss may be Reversed if the estimates behind the recoverable amount have changed because of better economic conditions, technology, demand, or the resolution of uncertainties. The carrying amount after the reversal must not exceed the amount it would have been, net of depreciation or amortisation, had no impairment been recognised (paragraphs 117 and 118). A reversal cannot lift the asset above its depreciated historical cost.
An impairment loss on goodwill is never reversed (paragraphs 124 and 125). The notes disclose the losses and reversals recognised in profit or loss, the line items that contain them, and losses recognised in other comprehensive income for revalued assets.
The ideas in more depth
Why research is expensed. Early on it is not yet clear that any benefit will follow. Why development needs six conditions. The business must show the asset is real and likely to pay. Amortisation versus impairment. Amortisation is a planned charge. Impairment is an unplanned write-down when the asset is worth less than recorded.
The higher of two. A rational owner would use or sell the asset, whichever gives more, so the recoverable amount is the higher. Impairment is not a concept. It is a test, which is why it is not on the list of accounting concepts. After impairment. The charge for later years is based on the lower carrying amount over the remaining life.
Sources: IAS 38 Intangible Assets: paragraphs 8, 54, 57, 63 and 68. IAS 36 Impairment of Assets: paragraphs 6, 9, 10, 12, 60, 117 and 118, and 124 and 125.
Worked example: Kano Dye Works
Scenario. A machine has a carrying amount of ₦22,000,000. It can be sold for ₦20,500,000 with selling costs of ₦700,000. It is expected to produce cash flows of ₦6,000,000 a year for four years, and the discount rate is 8%. The discount factors are 0.9259, 0.8573, 0.7938 and 0.7350. Separately, the company spent ₦340,000 on a market survey, ₦520,000 on research into dyes, ₦1,200,000 on a prototype after all six criteria were met, and ₦150,000 on advertising. Required: the impairment loss, and the treatment of the spending.
- FVLCTS.
20,500,000 − 700,000 = 19,800,000. - VIU.
The factors add to 0.9259 + 0.8573 + 0.7938 + 0.7350 = 3.3120.
VIU = 6,000,000 × 3.3120 = 19,872,000. - Recoverable amount. The higher of 19,800,000 and 19,872,000 is 19,872,000.
- Impairment loss.
22,000,000 − 19,872,000 = ₦2,128,000.
Dr Impairment loss 2,128,000, Cr Machine (accumulated impairment) 2,128,000.
The carrying amount becomes 19,872,000. - Spending. The market survey (340,000) and the research (520,000) are expensed. The advertising (150,000) is expensed. The prototype (1,200,000) is development meeting the criteria, so it is capitalised as an intangible asset.
- Amortisation.
If the prototype starts to earn on 1 October with a five-year life, the first year’s amortisation is 1,200,000 ÷ 5 × 3/12 = 60,000.
Common mistakes in the exam
- Capitalising research costs or advertising.
- Capitalising development costs when only some of the six criteria are met.
- Amortising an indefinite-life intangible.
- Taking the lower of FVLCTS and value in use instead of the higher.
- Forgetting that the loss goes to profit or loss unless a revaluation surplus exists.
- Reversing an impairment loss above the depreciated historical cost, or reversing a goodwill loss.
- Adding up discounted cash flows wrongly. Check the arithmetic.
Quick revision
- Intangible: identifiable, non-monetary, no physical substance, controlled, future benefits.
- Research: expense. Development: capitalise if all six criteria are met. Internally generated brands: never.
- Finite life: amortise, straight-line if unknown. Indefinite life: no amortisation, annual impairment test.
- Impairment: carrying amount above recoverable amount. Recoverable amount = higher of FVLCTS and VIU.
- Loss to profit or loss (or to the revaluation surplus first). Reversal capped. Goodwill never reversed.
Practice questions
These are original questions in the style of the Institute of Chartered Accountants of Nigeria (ICAN) exam. Try each one first.
Section A style: multiple choice
Question 1. Which is an intangible asset?
- A delivery van
- Inventory
- Cash
- A patent
Show the answer
D. A patent has no physical form, so it is an intangible asset.
Question 2. Research expenditure is:
- Always capitalised
- Always expensed
- Capitalised if feasible
- Shown as inventory
Show the answer
B. Research expenditure is always expensed as it is incurred.
Question 3. Development expenditure is capitalised when:
- Any one criterion is met
- It is large
- All the recognition criteria are met
- The auditor agrees
Show the answer
C. Development costs are capitalised only when all the recognition criteria are met.
Question 4. An indefinite-life intangible asset is:
- Not amortised but tested annually for impairment
- Amortised over 10 years
- Written off at once
- Depreciated on reducing balance
Show the answer
A. An asset with an indefinite life is not amortised, but is tested for impairment every year.
Question 5. A patent costs ₦1,800,000, has a six-year life and no residual value. The annual amortisation is:
- ₦300,000
- ₦360,000
- ₦180,000
- ₦1,800,000
Show the answer
A. 1,800,000 ÷ 6 = ₦300,000 a year.
Question 6. Recoverable amount is:
- The lower of the two
- The higher of fair value less costs to sell and value in use
- Cost less depreciation
- Market value
Show the answer
B. Recoverable amount is the higher of fair value less costs to sell and value in use.
Question 7. Carrying amount ₦5,000,000; FVLCTS ₦3,900,000; VIU ₦4,200,000. The impairment loss is:
- ₦1,100,000
- ₦800,000
- ₦300,000
- Nil
Show the answer
B. Recoverable amount 4,200,000. Loss 5,000,000 − 4,200,000 = 800,000.
Question 8. An impairment loss on a non-revalued asset is recognised in:
- Equity directly
- Current assets
- Sales
- Profit or loss
Show the answer
D. An impairment loss on an asset that is not revalued is recognised in profit or loss.
Question 9. Which impairment loss may NOT be reversed?
- Goodwill
- Equipment
- A patent
- A building
Show the answer
A. An impairment loss on goodwill may not be reversed.
Question 10. Which must be tested for impairment every year even with no indicator?
- A van
- Inventory
- Acquired goodwill
- Cash
Show the answer
C. Acquired goodwill must be tested for impairment every year, even with no sign of impairment.
Section B style: written questions
Question 11 (10 marks). (a) Define an intangible asset and state FOUR characteristics. (5 marks) (b) Distinguish research from development. (3 marks) (c) Give TWO examples of intangible assets. (2 marks)
Question 12 (20 marks). Ibadan Solar spent in a year: market research ₦340,000; research into materials ₦520,000; development after all criteria were met ₦1,200,000; advertising ₦150,000. The development asset has a five-year life from 1 October. A plant has a carrying amount of ₦8,400,000. Its fair value is ₦7,100,000 with selling costs of ₦300,000. It will produce cash flows of ₦2,500,000 a year for three years, discounted at 10% (factors 0.9091, 0.8264, 0.7513).
(a) State the treatment of each item of spending. (6 marks) (b) Calculate the amortisation for the first year. (3 marks) (c) Calculate the recoverable amount and the impairment loss. (8 marks) (d) Give the journal. (3 marks)
A further written question
Question 13 (10 marks). An asset cost ₦5,000,000, has a five-year life and no residual value, and is depreciated straight-line. At the end of Year 2 it is impaired to ₦2,000,000. At the end of Year 4 its recoverable amount is ₦1,500,000. (a) Calculate the impairment loss. (3 marks) (b) Calculate the later annual depreciation and the carrying amount at the end of Year 4 before any reversal. (3 marks) (c) State the maximum reversal. (4 marks)
Model answers
Show the model answer to Question 11
(a) An intangible asset is an identifiable non-monetary asset without physical substance. Any four: no physical substance; identifiable; non-monetary; controlled by the entity; expected future economic benefits; measurable cost; finite or indefinite life. (b) Research aims to gain new knowledge and is always expensed. Development applies research findings to create or improve products and is capitalised only if all criteria are met. (c) Patents; copyrights; trademarks; goodwill; software.
Show the model answer to Question 12
(a) Market research, research into materials and advertising are expensed. The development cost of 1,200,000 is capitalised as an intangible asset.
(b) 1,200,000 ÷ 5 × 3/12 = 60,000.
(c)
- FVLCTS = 7,100,000 − 300,000 = 6,800,000.
- VIU = 2,500,000 × (0.9091 + 0.8264 + 0.7513) = 2,500,000 × 2.4868 = 6,217,000.
- Recoverable amount = 6,800,000.
- Loss = 8,400,000 − 6,800,000 = ₦1,600,000.
(d) Dr Impairment loss 1,600,000, Cr Plant (accumulated impairment) 1,600,000.
Show the model answer to Question 13
(a)
- Carrying amount at the end of Year 2 = 5,000,000 − 2 × 1,000,000 = 3,000,000.
- Loss = 3,000,000 − 2,000,000 = ₦1,000,000.
(b)
- Remaining life 3 years: 2,000,000 ÷ 3 = ₦666,667 a year.
- Carrying amount at the end of Year 4 = 2,000,000 − 2 × 666,667 = ₦666,667.
(c)
- Without the impairment the carrying amount would be 5,000,000 − 4 × 1,000,000 = 1,000,000.
- The reversal cannot lift the asset above this, even though the recoverable amount is 1,500,000.
- Maximum reversal.
1,000,000 − 666,667 = ₦333,333.
Pathfinder on Intangible assets and impairment of assets
These are the ICAN Pathfinder questions that test this topic. ICAN owns the questions and the suggested solutions, so we point you to them and do not copy them. Open your Pathfinder, attempt each question under exam conditions, then check your answer against the notes above.
From the previous syllabus. Asks you to define an intangible non-current asset and give one example. Part (b) is a partnership question.
Revise first: Intangible assets
From the previous syllabus. Asks which item is not classified as an intangible asset when software, copyrights, licences, patents and plant are listed.
Revise first: Intangible assets
Question 6 asks which statement about goodwill is true. Question 13 asks which item is treated differently from the others on the statement of financial position, with intangible assets among the options.
Revise first: Intangible assets
Impairment, research and development and amortisation are new syllabus items. No past diet asks for them directly, so expect items on the classification of research and development spending, an amortisation charge, or an impairment loss from carrying amount, fair value and value in use.
Revise first: Impairment of assets
Source: ICAN Pathfinder, Financial Accounting. Diets covered: November Diet, 2015, November Diet, 2016 and May Diet, 2024. Research and development, amortisation and impairment are new syllabus items and no past diet asks for them directly. Diets before November 2014, and November Diet, 2024 onwards, are not covered here.
Spotted a mistake? Tell us and we will check it.